期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

瑞芬太尼静脉麻醉对窦性心动过缓者心率的影响 被引量：1

暂未订购
导出
摘要 目的评估瑞芬太尼全麻应用于窦性心动过缓患者的可行性.方法ASA 1～2级,无心脏病的患者;窦性心动过缓者(阿托品试验阴性)为A组,心律正常者为B组.观察两组病例在基础时、诱导时、插管时、切皮等各时点心率(HR)、血压(BP),手术结束时的SvO2值,围麻醉期应用阿托品、麻黄素药物的情况.结果两组病人瑞芬太尼麻醉后HR、BP均有显著变化,A组变化使HR处于正常低值,但血压仍在正常范围.结论瑞芬太尼全麻用于窦性心动过缓者,也是可行的,但应严密观察动态心电图,备好心肌正性药物应对等措施.
作者 黄伟 韦巧松 韦国温 李喜松 苏丽娜
机构地区 广西百色市人民医院麻醉科
出处 《广西医学》 CAS 2005年第10期1571-1572,共2页 Guangxi Medical Journal
关键词 瑞芬太尼 静脉全麻 窦性心动过缓
分类号 R614.2 [医药卫生—麻醉学]
  • 相关文献

参考文献4

  • 1Ouattara A,Boccara G,Kockler U,et al. Reimifentanil induces systemic arterial vasodilation in humans with a total artificial heart [ J ]. Anesthesiology, 2004,100 ( 7 ): 602～ 607.
  • 2耿志宇,单国瑾,宋琳琳,许幸,吴新民.瑞芬太尼普鲁泊福靶控输注静脉麻醉用于腹腔镜胆囊切除术[J].北京大学学报（医学版）,2003,35(5):549-552. 被引量：34
  • 3Zbinden AM, Petersen- Felix S, Thomson DA.Anesthetic depth defined using multiple noxious stimuli during isoflurane/oxygen anesthesia. Ⅱ Hemodynamic responses [ J ]. Anesthesiology, 1994,80: 261 ～267.
  • 4郭向阳,易杰,叶铁虎,罗爱伦,任洪智,黄宇光.瑞芬太尼用于术中麻醉[J].中国医学科学院学报,2004,26(1):66-69. 被引量：84

二级参考文献22

  • 1[1]Gepts E. Pharmacokinetics concepts for TCI anaesthesia[J]. Anaesthesia. 1998, 53: S4-12
  • 2[2]Glen JB. Development of 'Diprifusor': a TCI system for propofol[J]. Anaesthesia, 1998, 53: S13-21
  • 3[3]Glass PSA, Gan TJ, Howell S. A review of the pharmacokinetics and pharmacodynamics of remifentanil[J]. Anesth Analg, 1999, 89: S7-14
  • 4[4]Vuyk J, Mertens MJ, Olofsen E, et al. Propofol anesthesia and rational opioid selection[J]. Anesthesiology, 1997, 87: 1549-1562
  • 5[5]Hoymork SC, Reder J, Grimsmo B, et al. Bispectral index, predicted and measured drug levels of target-controlled infusions of remifentanil and propofol during laparoscopic cholecystectomy and emergence[J]. Acta Anaesth Scand, 2000, 44: 1138-1144
  • 6[6]Glass PSA, Shafer SL, Reves JG. Intravenous drug delivery system. In: Miller RD. Anesthesia[M].5th ed.USA: Churchill livingstone, 2001. 377-411
  • 7[7]Minto CF, Schnider TW, Egan TD, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil[J]. Anesthesiology, 1997,86:10-23
  • 8[8]Drover DR, Lemmens HJM. Population pharmacodynamics and pharmacokinetics of remifentanil as a supplement to nitrous oxide anesthesia for elective abdominal surgery[J]. Anesthesiology, 1998,89:869-877
  • 9[9]Lang E, Kaplia A, Shlugman D, et al. Reduction of isoflurane minimal alveolar concentration by remifentanil[J]. Anesthesiology, 1996,85:721-728
  • 10[10]Coetzee JF, Glen JB, Wium CA, et al. Pharmacokinetics model selection for target controlled infusions of propofol: Assessment of three parameter sets[J]. Anesthesiology, 1995,82:1328-1345

共引文献114

同被引文献7

  • 1谭乃杰,陈元禄,王建勇,李玉亮.自主神经系统在心律失常中的调控作用[J].中国心血管杂志,2005,10(2):98-100. 被引量：4
  • 2张才让.病态窦房结综合征的病因[J].临床内科杂志,1985,2(1):1-1.
  • 3陈新.临床心律失常学(上册)[M].北京:人民卫生出版社,2000.622.
  • 4Benditt DG, Sakaguchi S, Gddstein MA, et al. Sinus node dysfunction: Pathophysiology,clinleal features,evaluation and treatment. In Zipes DP and jalife J (eds) :Cardiac electrophysiology:From cell to bedside[ M ]. 2nd ed. Philadelphia,W. B. Saunders company,1994:215.
  • 5Bharati S, Lev M. The pathologic changes in the conduction system beyond the age of ninety[ J]. Am Heart J,1992,124(2) :486 - 496.
  • 6Zipcs DP. Autonomic modulation of cardic arthythmias. In Zipes DP and Jalife J (eds) :Cardiac dectro-physiology:From cell to bedside[ M] .2nd ed. Philadelphia,W. B. Saunders Company,1994:441 -454.
  • 7Kuarmby LM, Hartzell HC. Molecular biology of Gproteins and their role in cardiac excitability. In Zipes DP and Jalife J (eds) :Cardiac electro-physiology:From cell to bedside[ M]. 2nd ed. Philadelphia, W. B. Saunders Company, 1994:38.

引证文献1

二级引证文献4

广西医学
2005年 第10期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部